Waters Corp Q1 revenue beats estimates; raises 2026 revenue and EPS guidance on strong acquisition and organic growth

Waters Corporation reported Q1 2026 revenue of $1.267 billion, surpassing guidance due to strong organic growth of 13% and contributions from its recent acquisition of Biosciences and Diagnostic Solutions. Adjusted EPS rose 20% to $2.70 despite a GAAP loss driven by acquisition-related charges. The company raised its full-year 2026 organic revenue growth guidance to 6.5%-8% and adjusted EPS guidance to $14.40-$14.60, reflecting confidence in continued momentum from new product launches and integration synergies. Waters expects sustained growth across its divisions and plans a seamless integration of acquired businesses to drive long-term success.